Avalon GloboCare Corp
AVCO
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.26M
Close$
Share Statistics
| Market cap | $5.26 Million |
|---|---|
| Enterprise Value | $5.37 Million |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $-5.64 |
| Beta | 0.81 |
| Outstanding Shares | 15,792,440 |
Return
| Return on Equity | -80.76% |
|---|---|
| Return on Assets | -55.25% |
| Return on Invested Capital | -127.10% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 15.32 |
| Enterprise Value to EBIT | -0.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Avalon GloboCare Corp
7 employeesAvalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 rela...